Eris Lifesciences
BSE: 540596 | NSE: ERIS | ISIN: INE406M01024 | SECTOR: Biotechnology & DrugsRatios
- Management Effectiveness
- Margins
- Financial Strength
- Valuation
- Income Statement
- Growth
- Per Share Data
- Price and Volume
Return on average equity - 5 year average
23.20Net Income/employee - trailing 12 month
10,67,923.00Revenue/employee - most recent fiscal year
48,50,746.00Return on investment - most recent fiscal year
14.19Return on average assets - most recent fiscal year
12.60Receivables turnover - most recent fiscal year
7.56Return on investment - trailing 12 month
-Return on average assets - trailing 12 month
-Inventory turnover - most recent fiscal year
1.93Inventory turnover - trailing 12 month
-Revenue/employee - trailing 12 month
52,45,254.00Return on average assets - 5 year average
17.62Net Income/employee - most recent fiscal year
10,77,029.00Return on average equity - trailing 12 month
-Receivables turnover - trailing 12 month
-Asset turnover - most recent fiscal year
0.57Asset turnover - trailing 12 month
-Return on average equity - most recent fiscal year
18.62Return on investment - 5 year average
20.12